by Jim | Jan 24, 2019 | Press Release, Press Releases
Press Release Source: Vitro Diagnostics, Inc. Vitro Biopharma 2018 CEO Shareholder Letter:Record Revenues from Stem Cell Treatments Lead to 4th Quarter BreakevenCashflow & Growth...
by Jim | Dec 12, 2017 | Technical Content
Cancer therapy traditionally involves surgery, radiation or chemotherapy to kill cancer cells that are normal cells lacking control that limit growth. Cancer cells produce continually growing tumors that spread to other tissues, and eventually kill. Since the early...
by Jim | Nov 29, 2017 | Company News, Press Release
Golden, Colorado—November 21, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced the filing of a USPTO patent application regarding a novel stem cell line and its application to treatment of a variety of conditions including skeletal muscular,...
by Jim | Oct 31, 2017 | Blogs, Technical Content
Scientists at the University of Miami Miller School of Medicine completed a clinical trial showing safety and efficacy of stem cell therapy in treatment of frailty, a common aging symptom caused by reduced function of stem cells and inflammation.1 Stem cells in the...
by Jim | Aug 9, 2017 | Company News, Press Release
Golden, Colorado—August 8, 2017 —Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced initial results of a Phase I clinical trial testing the effects of its proprietary stem cell activation compounds for safety and efficacy in autistic patients....
